Literature DB >> 1373234

Synthesis and base-pairing properties of the nuclease-resistant alpha-anomeric dodecaribonucleotide alpha-[r(UCUUAACCCACA)].

F Debart1, B Rayner, G Degols, J L Imbach.   

Abstract

The non natural oligoribonucleotide alpha-[r(UCUUAACCCACA)] consisting exclusively of alpha-anomeric ribonucleoside units was synthesized according to the phosphoramidite methodology and the solid support technology. For this purpose, the base-protected alpha-ribonucleosides were synthesized and converted into their O-methylphosphoramidites. Assembling was carried out on a DNA synthesizer with an average efficiency of 97% per step. Base composition of this nuclease-resistant alpha-RNA strand was ascertained after chemical and enzymatic hydrolysis and HPLC analysis of the hydrolysate. Whereas no spectroscopic evidence of base pairing was found above 0 degrees C between alpha-[r(UCUUAACCCACA)] and beta-[d(TGTGGGTTAAGA)], a clear UV absorbance transition (Tm 25.5 degrees C) was observed during the hybridization of the same alpha-RNA strand with beta-[d(AGAATTGGGTGT)]. In this latter case, the mixing curve titration suggests formation at low temperature of a triplex involving two alpha-RNA and one beta-DNA strands. Moreover, this alpha-decaribonucleotide complementary in parallel orientation of the splice receptor of HIV-1 tat mRNA was found to inhibit (10 microM less than ED50 less than 20 microM), with apparent lack of sequence specificity, the de novo HIV-1 infection in cultured cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373234      PMCID: PMC312158          DOI: 10.1093/nar/20.6.1193

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  25 in total

1.  Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.

Authors:  S Harada; Y Koyanagi; N Yamamoto
Journal:  Science       Date:  1985-08-09       Impact factor: 47.728

Review 2.  Oligonucleotide analogues as potential chemotherapeutic agents.

Authors:  G Zon
Journal:  Pharm Res       Date:  1988-09       Impact factor: 4.200

3.  Alpha-DNA.IX: Parallel annealing of alpha-anomeric oligodeoxyribonucleotides to natural mRNA is required for interference in RNase H mediated hydrolysis and reverse transcription.

Authors:  C Gagnor; B Rayner; J P Leonetti; J L Imbach; B Lebleu
Journal:  Nucleic Acids Res       Date:  1989-07-11       Impact factor: 16.971

4.  Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides.

Authors:  J Goodchild; S Agrawal; M P Civeira; P S Sarin; D Sun; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

5.  Comparative activity of alpha- and beta-anomeric oligonucleotides on rabbit beta globin synthesis: inhibitory effect of cap targeted alpha-oligonucleotides.

Authors:  J R Bertrand; B Rayner; J L Imbach; C Paoletti; C Malvy
Journal:  Biochem Biophys Res Commun       Date:  1989-10-16       Impact factor: 3.575

6.  Inhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleoside methylphosphonates.

Authors:  P S Sarin; S Agrawal; M P Civeira; J Goodchild; T Ikeuchi; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

7.  Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus.

Authors:  S Agrawal; J Goodchild; M P Civeira; A H Thornton; P S Sarin; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

Review 8.  Oligodeoxynucleotides as inhibitors of gene expression: a review.

Authors:  C A Stein; J S Cohen
Journal:  Cancer Res       Date:  1988-05-15       Impact factor: 12.701

9.  Inhibition of human immunodeficiency virus by using an oligonucleoside methylphosphonate targeted to the tat-3 gene.

Authors:  J A Zaia; J J Rossi; G J Murakawa; P A Spallone; D A Stephens; B E Kaplan; R Eritja; R B Wallace; E M Cantin
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

10.  alpha-DNA II. Synthesis of unnatural alpha-anomeric oligodeoxyribonucleotides containing the four usual bases and study of their substrate activities for nucleases.

Authors:  F Morvan; B Rayner; J L Imbach; S Thenet; J R Bertrand; J Paoletti; C Malvy; C Paoletti
Journal:  Nucleic Acids Res       Date:  1987-04-24       Impact factor: 16.971

View more
  6 in total

1.  Hybrid characteristics of oligonucleotides consisting of isonucleoside 2',5'-anhydro-3'-deoxy-3'-(thymin-1-yl)-D-mannitol with different linkage modes.

Authors:  Z Lei; L Zhang; L R Zhang; J Chen; J M Min; L H Zhang
Journal:  Nucleic Acids Res       Date:  2001-04-01       Impact factor: 16.971

2.  alpha-Oligodeoxyribonucleotide N3'-->P5' phosphoramidates: synthesis and duplex formation.

Authors:  K Pongracz; S M Gryaznov
Journal:  Nucleic Acids Res       Date:  1998-02-15       Impact factor: 16.971

3.  4'-Thio-oligo-beta-D-ribonucleotides: synthesis of beta-4'-thio-oligouridylates, nuclease resistance, base pairing properties, and interaction with HIV-1 reverse transcriptase.

Authors:  L Bellon; J L Barascut; G Maury; G Divita; R Goody; J L Imbach
Journal:  Nucleic Acids Res       Date:  1993-04-11       Impact factor: 16.971

4.  Incorporation of hexose nucleoside analogues into oligonucleotides: synthesis, base-pairing properties and enzymatic stability.

Authors:  K Augustyns; F Vandendriessche; A Van Aerschot; R Busson; C Urbanke; P Herdewijn
Journal:  Nucleic Acids Res       Date:  1992-09-25       Impact factor: 16.971

Review 5.  Review of α-nucleosides: from discovery, synthesis to properties and potential applications.

Authors:  Guangcheng Ni; Yuqi Du; Fan Tang; Jiang Liu; Hang Zhao; Qianming Chen
Journal:  RSC Adv       Date:  2019-05-07       Impact factor: 4.036

6.  Anomeric DNA Strand Displacement with α-D Oligonucleotides as Invaders and Ethidium Bromide as Fluorescence Sensor for Duplexes with α/β-, β/β- and α/α-D Configuration.

Authors:  Aigui Zhang; Dasharath Kondhare; Peter Leonard; Frank Seela
Journal:  Chemistry       Date:  2022-07-04       Impact factor: 5.020

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.